AB181031

Anti-C8orf30A antibody [EPR13203-28]

RabMAb
Recombinant
What is this?

Be the first to review this product! Submit a review

(1 Publication)

Rabbit Recombinant Monoclonal C8orf30A antibody. Suitable for IHC-P, IP, WB, ICC/IF and reacts with Human samples. Cited in 1 publication.

View Alternative Names

C8orf30A, C8orf30B, FAM203A, FAM203B, HGH1, Co-chaperone protein HGH1 homolog

5 Images

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Immunohistochemical analysis of formalin-fixed paraffin-embedded Human breast carcinoma tissue labeling C8orf30A with ab181031 at 1/100 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

IHC-P

Supplier Data

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Immunohistochemical analysis of formalin-fixed paraffin-embedded Human endometrium tissue labeling C8orf30A with ab181031 at 1/100 dilution followed by pre-diluted HRP-conjugated secondary antibody and counter-stained with Hematoxylin.

Perform heat mediated antigen retrieval with citrate buffer pH 6 before commencing with IHC staining protocol.

Immunocytochemistry/ Immunofluorescence - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

ICC/IF

Supplier Data

Immunocytochemistry/ Immunofluorescence - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Immunofluorescent analysis of HeLa cells (-20°C acetone-fixed) labeling C8orf30A with ab181031 at 1/100 dilution followed by Goat anti rabbit IgG (Alexa Fluor® 488) secondary at 1/200 dilution and counter-stained with DAPI (blue).

Supplier Data

Immunoprecipitation - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Western blot analysis of immunoprecipitation pellet from HeLa cell lysate (+) or a negative control (-) immunoprecipitated using ab181031 at 1/40 dilution.

Secondary : Anti-Rabbit IgG (HRP), specific to the non-reduced form of IgG at 1/1500 dilution.

All lanes:

Immunoprecipitation - Anti-C8orf30A antibody [EPR13203-28] (ab181031)

Predicted band size: 42 kDa

false

Supplier Data

Western blot - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

All lanes:

Western blot - Anti-C8orf30A antibody [EPR13203-28] (ab181031) at 1/5000 dilution

Lane 1:

Human fetal liver tissue lysate at 20 µg

Lane 2:

Human spleen tissue lysate at 20 µg

Lane 3:

HeLa cell lysate at 20 µg

Lane 4:

Caco-2 cell lysate at 20 µg

Secondary

All lanes:

Goat Anti-Rabbit IgG, (H+L), Peroxidase conjugated at 1/1000 dilution

Predicted band size: 42 kDa

true

Carrier free

Anti-C8orf30A antibody [EPR13203-28] - BSA and Azide free

Key facts

Host species

Rabbit

Clonality

Monoclonal

Clone number

EPR13203-28

Isotype

IgG

Carrier free

Reacts with

Human

Applications

WB, IP, ICC/IF, IHC-P

applications

Immunogen

The exact immunogen used to generate this antibody is proprietary information.

style

left-column

style

left-column

Reactivity data

{ "title": "Reactivity Data", "filters": { "stats": ["", "Species", "Dilution Info", "Notes"], "tabs": { "all-applications": {"fullname" : "All Applications", "shortname": "All Applications"}, "IHCP" : {"fullname" : "Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections)", "shortname":"IHC-P"}, "IP" : {"fullname" : "Immunoprecipitation", "shortname":"IP"}, "WB" : {"fullname" : "Western blot", "shortname":"WB"}, "ICCIF" : {"fullname" : "Immunocytochemistry/ Immunofluorescence", "shortname":"ICC/IF"} }, "product-promise": { "all": "all", "testedAndGuaranteed": "tested", "guaranteed": "expected", "predicted": "predicted", "notRecommended": "not-recommended" } }, "values": { "Human": { "IHCP-species-checked": "testedAndGuaranteed", "IHCP-species-dilution-info": "1/50 - 1/100", "IHCP-species-notes": "", "IP-species-checked": "testedAndGuaranteed", "IP-species-dilution-info": "1/40", "IP-species-notes": "", "WB-species-checked": "testedAndGuaranteed", "WB-species-dilution-info": "1/1000 - 1/10000", "WB-species-notes": "", "ICCIF-species-checked": "testedAndGuaranteed", "ICCIF-species-dilution-info": "1/50 - 1/100", "ICCIF-species-notes": "" } } }

style

left-column

Product details

Patented technology
Our RabMAb^® technology is a patented hybridoma-based technology for making rabbit monoclonal antibodies. For details on our patents, please refer to RabMAb^® patents.

What are the advantages of a recombinant monoclonal antibody?
This product is a recombinant monoclonal antibody, which offers several advantages including:

- High batch-to-batch consistency and reproducibility
- Improved sensitivity and specificity
- Long-term security of supply
- Animal-free batch production

For more information, read more on recombinant antibodies.

style

left-column

Properties and storage information

Form

Liquid

Purification technique

Affinity purification Protein A

Storage buffer

Preservative: 0.01% Sodium azide Constituents: PBS, 40% Glycerol (glycerin, glycerine), 0.05% BSA

Shipped at conditions

Conditional Ambient

Appropriate short-term storage duration

1-2 weeks

Appropriate short-term storage conditions

+4°C

Appropriate long-term storage conditions

-20°C

Aliquoting information

Upon delivery aliquot

Storage information

Avoid freeze / thaw cycle

style

left-column

Supplementary information

This supplementary information is collated from multiple sources and compiled automatically.

The C8orf30A protein also called Chromosome 8 open reading frame 30A has a molecular mass of about 12 kDa. This protein's function involves cellular processes related to energy metabolism and plays an unclear yet significant mechanical role in the cells. Expression of C8orf30A occurs in tissues that display high metabolic activity such as liver and muscle tissues. Current research suggests its activity might impact the efficiency of cellular energy utilization.

Biological function summary

C8orf30A contributes to the regulation of mitochondrial function and energy metabolism. It forms a part of a larger protein complex that participates in the cellular energy management. The presence of this protein influences the mitochondrial respiratory chain affecting the production of ATP—a critical energy currency of the cell. The modulation of energy dynamics by C8orf30A highlights its importance in maintaining cellular energy homeostasis.

Pathways

C8orf30A involvement reflects in the regulation of oxidative phosphorylation and glycolytic pathways. This protein interacts closely with enzymes and other proteins within these pathways to modulate energy production and balance. It associates with proteins like ATP synthase and complexes involved in electron transport reflecting an essential integrative role within metabolic pathways to harness energy efficiently.

Changes in C8orf30A levels connect to metabolic disorders including diabetes and metabolic syndrome. The protein's regulation influences factors related to these diseases impacting insulin sensitivity and energy utilization in cells. C8orf30A interacts with proteins such as glucose transporters and alters their function emphasizing its role in disease progression and providing potential targets for therapeutic intervention.

style

left-column

style

left-column

Product protocols

For this product, it's our understanding that no specific protocols are required. You can visit:

Visit the General protocols
Visit the Troubleshooting

style

left-column

Target data

Co-chaperone involved in the folding of nascent eukaryotic elongation factor eEF2, an essential component of the translation machinery. Recognizes a non-native conformation in the central domain of eEF2 and recruits the chaperonin-containing T-complex (TRiC) to the C-terminal region of the nascent polypeptide, preventing unproductive interactions and promoting efficient folding of the N-terminal GTPase domain. May also assist in eEF2 maturation by recruiting the molecular chaperone Hsp90.

See full target information HGH1

style

left-column

Publications (1)

Recent publications for all applications. Explore the full list and refine your search

Molecular medicine reports 28: PubMed37326104

2023

Construction of ceRNA regulatory networks for osteoporosis.

Applications

Unspecified application

Species

Unspecified reactive species

Hongtao Chen,Hailong Wang,Xu Liu,Long Li,Yiliyaer Abudusimu,Yilihamu Tuoheti

View all publications

style

left-column

style

left-column

style

right-column

Product promise

We are committed to supporting your work with high-quality reagents, and we're here for you every step of the way. In the unlikely event that one of our products does not perform as expected, you're protected by our Product Promise.

For full details, please see our Terms & Conditions

Please note: All products are 'FOR RESEARCH USE ONLY. NOT FOR USE IN DIAGNOSTIC OR THERAPEUTIC PROCEDURES'.

For licensing inquiries, please contact partnerships@abcam.com

Anti-C8orf30A antibody [EPR13203-28]

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Immunohistochemistry (Formalin/PFA-fixed paraffin-embedded sections) - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Immunocytochemistry/ Immunofluorescence - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Immunoprecipitation - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Western blot - Anti-C8orf30A antibody [EPR13203-28] (AB181031)

Related conjugates and formulations (1)

Key facts

Host species

Clonality

Clone number

Isotype

Carrier free

Reacts with

Applications

Immunogen

Complementary Products

Primary Antibodies

Primary Antibodies

Primary Antibodies

Primary Antibodies

Reactivity data

Product details

Properties and storage information

Form

Purification technique

Storage buffer

Shipped at conditions

Appropriate short-term storage duration

Appropriate short-term storage conditions

Appropriate long-term storage conditions

Aliquoting information

Storage information

Supplementary information

Biological function summary

Pathways

Product protocols

Target data

Publications (1)

Product promise